DataMeds AI, Inc. Proceeds from Long-term Lines of Credit
DataMeds AI, Inc. (MEDS) reported Proceeds from Long-term Lines of Credit of -$310.56 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-05-19
- DataMeds AI, Inc. proceeds from long-term lines of credit for the quarter ending 2025-03-31 was -$310.56K.
| Period end | Proceeds from Long-term Lines of Credit 3 month |
|---|---|
| 2025-03-31 | -$310.56K 10-Q · filed 2026-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |